Using B-OK Bottles to boost HIV and ART literacy in South Africa

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized trial evaluates three approaches to patient education about HIV treatment in Gauteng, South Africa. Participants are adults living with HIV who will be assigned to: standard-of-care information, in-person B-OK bottle education, or a video-based B-OK bottle education. The study aims to see which method most effectively increases knowledge and may influence adherence and attitudes toward U=U. Outcomes focus on understanding of ART and the concept that undetectable viral load means untransmittable HIV. The investigation is conducted with collaboration between the University of Pennsylvania, HE2RO, and the University of the Witwatersrand, at the HE2RO offices in Johannesburg.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Aged 18 years or older
* Residing in Gauteng
* Able to understand and communicate in English or another study-supported language
* Willing to attend an in-person study visit at the HE2RO offices
* Willing to provide contact details for follow-up at six weeks

Exclusion Criteria:

* Unwilling or unable to provide written informed consent for study participation

Where it's running

• Health Economics and Epidemiology Research Office (HE2RO), University of the Witwatersrand
  Johannesburg, Gauteng, South Africa Recruiting

Study contacts

• Principal investigator: Aaron Richterman, PhD — University of Pennsylvania
• Study coordinator: Divya Pandey, PhD
• Email: Divya.Pandey@PennMedicine.upenn.edu
• Phone: 6123230324

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Evaluating a new approach to improve HIV testing and treatment in Alabama

  This study is testing a new way to improve HIV testing and treatment in Mobile County, Alabama, by bringing testing to the community and helping people get care quickly.

  Recruiting University of Alabama at Birmingham · Birmingham, Alabama · NCT05384145

• Project SHIELD 2.0: Police Education to Support Public Health in Kentucky

  Aimed at police in Kentucky, this program tests whether SHIELD training given to officers, with health workers helping deliver it, can reduce drug-related arrests and steer people who use drugs toward MOUD and other health services.

  Recruiting Johns Hopkins Bloomberg School of Public Health · Lexington, Kentucky · NCT07804121

• New ways to diagnose lymphoma and multicentric Castleman disease in people living with HIV

  This study tests a quick, point-of-care nucleic acid test to help diagnose lymphoma and multicentric Castleman disease in people living with HIV in sub-Saharan Africa.

  Recruiting Indiana University · Lilongwe · NCT07793006

• Bridge to Belonging: A Peer‑Led Program to Reduce Loneliness and Depression in older gay and bisexual men with HIV

  This program tests a peer-delivered, manualized approach to help men aged 50+ with HIV connect to LGBTQ+-affirming elder services to see if it reduces loneliness and depressive symptoms.

  Recruiting Fenway Community Health · Boston, Massachusetts · NCT07762066

• HIV vaccine test in healthy adults using CH505 nanoparticles and mRNA boosters

  This early-stage study will test the safety and immune responses of CH505 vaccine regimens in healthy adults to see if they can trigger HIV-specific immune protection.

  Recruiting at 2 sites Phase 1 National Institute of Allergy and Infectious Diseases (NIAID) · San Francisco, California and 7 other locations · NCT07757802

• Stigma-reducing program to help women who use drugs stay in HIV care

  This test checks whether a stigma-reduction program helps women living with HIV who use drugs stay engaged in HIV care in Ukraine.

  Recruiting Johns Hopkins Bloomberg School of Public Health · Kyiv, Kyiv Oblast · NCT07751978

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.